New Study Finds that CBD Could be Used to Treat Acute Dental Pain
A recently published study from researchers at Rutgers University and the University of Texas found that CBD may be able to alleviate acute dental pain. The study also discovered that the cannabinoid CBD may provide an effective and safer alternative to opioids. The results of the study were published in the Journal of Dental Research, and the team responsible for the research said that research shows that a single dose of CBD is as strong as widely accepted analgesics for dental pain. Currently, OTC medications like ibuprofen and acetaminophen are the first choice for pain relief for emergency dental pain. But, many patients aren’t able to take those pain relievers or they do not find they provide much relief. For those who cannot take OTC pain relievers, opioids are the next choice for many dentists to provide their patients with pain relief. Because of this, dentists have historically been among the most pervasive prescribers of opioids according to the lead author of the research study.
Regulators in Maine Say a High Percentage of the State’s MMJ is Contaminated
Maine’s Office of Cannabis Policy (OCP) tested cannabis samples for contaminants and discovered that 50 out of 120 samples would have failed to pass laboratory tests for adult-use cannabis standards for the state. Results indicated that contaminants found include yeast, pesticides, mold, and heavy metals. This information has caused regulators to push to make changes that would “modernize” Maine’s MMJ program because medical marijuana is not subject to the same testing standards as adult-use cannabis. However, officials have gotten pushback from both caregivers and cultivators who insist their medical cannabis products are safe. However, the results from samples showed that the pesticide myclobutanil was commonly present, exceeding the allowable threshold in eight samples.
Missouri Cannabis Officials Revoke Manufacturing License of Delta Extraction
Delta Extraction is the cannabis company at the center of a recall issue that began in August in Missouri. Initially, regulators suspended the company’s license and recalled 62,000 products manufactured by Delta Extraction, including edibles and vapes. In addition to the problems surrounding the recalled THC-infused products, the Missouri Division of Cannabis Regulation (DCR) also accused the company of using out-of-state THCA to manufacture the products that would be sold in Missouri, which is a clear violation of state rules. DCR officially revoked Delta Extraction’s license in light of new allegations, including failing to comply with seed-to-sale tracking requirements, using false traceability data, and failing to ensure that all cannabis products were tested and in compliance with regulations.
